The participants of the Merah Putih (Red and White) vaccine’s clinical trial will be observed for one year, lead researcher for the clinical trial at .
JAKARTA - Indonesia will seek to launch a homegrown Covid-19 vaccine in August, with the first phase of clinical trials for the Merah Putih vaccine now underway.
. Read more at straitstimes.com.
Indonesia will seek to launch a home-grown Covid-19 vaccine in August, with the first phase of clinical trials for the Merah Putih vaccine now under way.
The nation will seek to launch a home-grown Covid-19 vaccine in August, with the first phase of clinical trials for the Merah Putih vaccine now under way.
The first phase clinical trial of the domestically-produced Merah Putih vaccine is a huge leap for independent vaccine development in Indonesia, the National .